drugset / Trial / NCT00752661
An Exploratory Study of Tramadol Hydrochloride in Patients With Osteoarthritis of the Knee or Low Back Pain
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find the clinical dose range of an active ingredient of JNS013 - Tramadol hydrochloride in chronic-pain patients who cannot attain a sufficient analgesic effect from non-steroidal anti-inflammatory drugs (NSAIDs).
Timeline
- Start
- 2007-06
- Primary completion
- 2007-11
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tramadol | Other / unclassified | 25 mg | Oral |
| Subject | Tramadol | Other / unclassified | 100 mg | Oral |